Published on Sep 22, 2016
Relief
over the Federal Reserve's slow-and-steady rates plans fueled another
day of gains. The Nasdaq clocked a record close for the second session
in a row. Sarepta Therapeutics rose after announcing plans to offer $225
No comments:
Post a Comment